Name | nitroflurbiprofen |
---|---|
Synonyms |
HCT-1026
4-nitrooxybutyl 2-(3-fluoro-4-phenylphenyl)propanoate NO-flurbiprofen Flurbiprofen nitroxybutyl ester Nitroxybutyl flurbiprofen Nitroflurbiprofen Flurbinitroxybutylester |
Description | Nitroflurbiprofen is a cyclooxygenase (COX) inhibitor with nitric oxide (NO)-donating properties, modulates the increased intrahepatic vascular tone in portal hypertensive cirrhotic rats. |
---|---|
Related Catalog | |
Target |
COX |
In Vivo | In vivo hemodynamic measurements (n = 8/condition) and evaluation of the increased intrahepatic resistance by in situ perfusion (n=5/condition) are performed in rats with thioacetamide-induced cirrhosis that receive either Nitroflurbiprofen (45 mg/kg), Flurbiprofen (30 mg/kg, equimolar concentration to Nitroflurbiprofen), or vehicle by intraperitoneal injection 24 hours and 1 hour prior to the measurements. Treatment with Nitroflurbiprofen, an NO-releasing cyclooxygenase inhibitor, improves portal hypertension without major adverse effects in thioacetamide-induced cirrhotic rats by attenuating intrahepatic vascular resistance, endothelial dysfunction, and hepatic hyperreactivity to vasoconstrictors[1]. |
Animal Admin | Rats[1] Male Wistar rats, weighing 200-250 g, are used. After 18 weeks of TAA administration, cirrhotic rats are equally (n=8/group) and randomly allocated to one of the following groups: intraperitoneal injection, 24 hours and 1 hour prior to the measurements, with Nitroflurbiprofen (45 mg/kg), Flurbiprofen (30 mg/kg, equimolar concentration to Nitroflurbiprofen), or vehicle (250 μL DMSO:250 μL isotonic saline). The used dose is based on a dose-finding study (n=5 per condition). The concentrations of Nitroflurbiprofen (15 mg/kg) and Flurbiprofen (7.5 mg/kg, equimolar concentration to Nitroflurbiprofen Flurbiprofen) are started, then are increased the dose to Nitroflurbiprofen 22.5 mg/kg and Flurbiprofen 15 mg/kg, and, finally, Nitroflurbiprofen 45 mg/kg and Flurbiprofen 30 mg/kg. The last dose regimen has the most profound hemodynamic effects. |
References |
Density | 1.214g/cm3 |
---|---|
Boiling Point | 468.8ºC at 760 mmHg |
Molecular Formula | C19H20FNO5 |
Molecular Weight | 361.36400 |
Flash Point | 237.3ºC |
Exact Mass | 361.13300 |
PSA | 81.35000 |
LogP | 4.65110 |
Vapour Pressure | 5.79E-09mmHg at 25°C |
Index of Refraction | 1.537 |
Storage condition | 2-8℃ |